Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1989
Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens
M J Zelefsky, H I Scher, J D Forman, et al.
Cancer Research
|
January 1, 1992
Use of adaptive control with feedback to individualize suramin dosing
H I Scher, D I Jodrell, J M Iversen, et al.
Cancer Treatment Reports
|
October 1, 1987
Gallium nitrate in prostatic cancer: evaluation of antitumor activity and effects on bone turnover
H I Scher, T Curley, N Geller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer
W K Kelly, I Osman, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications
R A Ghossein, H I Scher, W L Gerald, et al.
Seminars in Urology
|
August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience
W R Fair, H Scher, H Herr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer
M C Graham, H I Scher, G B Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer
W K Kelly, H I Scher, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1990
Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease
H I Scher, T Curley, N Geller, et al.
Human Gene Therapy
|
February 9, 2026
Systemic Administration of AAV9-G266A with Focused Ultrasound Enables Robust Brain Transduction with Minimal Liver Transduction
Andrew T Nelson, Aidan Smith, Colleen T Curley, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1989
Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens
M J Zelefsky, H I Scher, J D Forman, et al.
Cancer Research
|
January 1, 1992
Use of adaptive control with feedback to individualize suramin dosing
H I Scher, D I Jodrell, J M Iversen, et al.
Cancer Treatment Reports
|
October 1, 1987
Gallium nitrate in prostatic cancer: evaluation of antitumor activity and effects on bone turnover
H I Scher, T Curley, N Geller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer
W K Kelly, I Osman, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications
R A Ghossein, H I Scher, W L Gerald, et al.
Seminars in Urology
|
August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience
W R Fair, H Scher, H Herr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 2, 1999
Rhenium-186-labeled hydroxyethylidene diphosphonate dosimetry and dosing guidelines for the palliation of skeletal metastases from androgen-independent prostate cancer
M C Graham, H I Scher, G B Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancer
W K Kelly, H I Scher, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1990
Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease
H I Scher, T Curley, N Geller, et al.
Human Gene Therapy
|
February 9, 2026
Systemic Administration of AAV9-G266A with Focused Ultrasound Enables Robust Brain Transduction with Minimal Liver Transduction
Andrew T Nelson, Aidan Smith, Colleen T Curley, et al.
Page
of 3